Pancreatic Cancer Research

Clinical trialPhase 1Suspended

Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and Feasibility Study

NCT07173374↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Stopped earlyThe study was terminated early due to slow patient accrual. Enrollment was substantially lower than anticipated, making it unlikely to achieve the planned sample size within a reasonable timeframe. (Enrollment)
Phase
Phase 1
Status
Suspended
Study type
Interventional
Start
10 September 2025
Expected end
1 September 2028
Enrollment
24 participants
Sites
1
Primary outcomes
Maximum Tolerated Dose (MTD); Dose-Limiting Toxicities (DLTs)
Sponsor
Other
Results posted
No
Last update
1 May 2026

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 12